Simon Peeke will be the only dead wood that will be sitting on the board post the sale. Hopefully there's little need for "investor relations" NED.
RGT Is the ASX OK? Argent Biopharma plummets as it leaves the bourse one day after Marley spoon; low liquidity blamed